María Luisa Martín

Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis

Norma C. Gutiérrez, M. Castellanos, María Luisa Martín et al. · Leukemia · 2006 · 186 citations

Hematological Malignancy, Transplantation, Marrow Transplantation +12

Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q

Mar Mallo, José Cervera, Julie Schanz et al. · Leukemia · 2010 · 120 citations · Full text

Hematological Malignancy, Deletion 5Q, Myelodysplastic Syndrome +6

SPECIFIC INTRAVENOUS CARBOHYDRATE THERAPY A NEW CONCEPT IN INHIBITING ANTIBODY-MEDIATED REJECTION—EXPERIENCE WITH ABO-INCOMPATIBLE CARDIAC ALLOGRAFTING IN THE BABOON

David K. C. Cooper, Y. YE, Marek Niekrasz et al. · Transplantation · 1993 · 104 citations

Immunology, Immunotherapy, Carbohydrate Epitopes +16

Double Vs Single Autologous Stem Cell Transplantation After Bortezomib-Based Induction Regimens For Multiple Myeloma: An Integrated Analysis Of Patient-Level Data From Phase European III Studies

Michèle Cavo, Hans Salwender, Laura Rosiñol et al. · Blood · 2013 · 80 citations

Quercetin 3,7-dimethyl ether: a vasorelaxant flavonoid isolated from <i>Croton schiedeanus</i> Schlecht

Mario Guerrero, Pilar Puebla, Rosalı́a Carrón et al. · Journal of Pharmacy and Pharmacology · 2002 · 66 citations · Full text